相关实验视频

Updated: Jun 28, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

针对BRD4:头角状细胞癌的潜在治疗策略 (综述)

Voraporn Yongprayoon¹, Napasporn Wattanakul¹, Winnada Khomate¹

¹Princess Srisavangavadhana College of Medicine, Chulabhorn Royal Academy, Bangkok 10210, Thailand.

Oncology reports

|April 12, 2024

概括

含基因的蛋白4 (BRD4) 是关键的基因表达调节器,与癌症有关. 向BRD4对治疗头部和部状细胞癌 (HNSCC) 有望带来潜在的副作用较少.

科学领域:

分子生物学分子生物学
表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.
在瘤学瘤学.

背景情况:

作为BET蛋白家族的一员,BRD4是一种调节基因表达和染色质重塑的染色质关联蛋白.
它的功能与正常发育,纤维化,炎症和癌症有关,它驱动瘤细胞的增殖,生存,迁移和耐药性.
在各种癌症中,BRD4经常过度表达,这使得它成为潜在的治疗点.

研究的目的:

探索BRD4在癌症中的作用,特别是在头部和部状细胞癌 (HNSCC) 中.
评估BRD4抑制剂作为HNSCC的治疗策略.
调查BRD4向的潜力,使HNSCC对传统疗法更敏感,并减少副作用.

主要方法:

开发特定的BRD4抑制剂.
在癌症模型中对BRD4抑制剂进行临床前测试.
研究BRD4抑制剂用于各种癌症的临床试验.

主要成果:

在临床前癌症模型中,BRD4抑制已经显示出有前途的结果.
目前,一些BRD4抑制剂正在进行临床试验.
向BRD4可能会使HNSCC对化疗和放射治疗敏感,从而使治疗减强.

结论:

BRD4 是 HNSCC 的一个有前途的治疗点.
抑制BRD4提供了一种改善HNSCC治疗结果和减少不良影响的策略.
需要进一步的研究来阐明BRD4在HNSCC中的机制,并优化治疗方案.

关键词:

含 bromodomain 的蛋白质 4 的蛋白质.为了缓和局势的升级.头部和部状细胞癌瘤敏感化敏感化有针对性的治疗.

更多相关视频

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

The Retinoblastoma Gene

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...